Stay updated on Study of ARO-HSD in NASH Clinical Trial
Sign up to get notified when there's something new on the Study of ARO-HSD in NASH Clinical Trial page.

Latest updates to the Study of ARO-HSD in NASH Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new page version. This is a maintenance update and does not change the study details, eligibility criteria, or results presented.SummaryDifference0.1%

- Check23 days agoChange DetectedThe disease terminology was updated by adding 'Steatotic Liver Disease' and removing 'Fatty Liver Disease' to reflect current nomenclature.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page revision stamp was updated to v3.6.3, indicating a metadata-level update to the study record display. This appears to be a minor system update rather than a change to the study data or user-facing content.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a small update to the page version without changing core content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now includes new guidance sections and explicitly notes that participant recruitment is closed, clarifying how to engage with the study. At the same time, a header label was adjusted and a new revision version was added, reflecting minor formatting and versioning updates.SummaryDifference0.4%

Stay in the know with updates to Study of ARO-HSD in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of ARO-HSD in NASH Clinical Trial page.